Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q45001564

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis.

@en

Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis.

@nl

type

Item

label

Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis.

@en

Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis.

@nl

prefLabel

Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis.

@en

Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis.

@nl

P1476

Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis.

@en

P2093

Angelika Thon

http://www.w3.org/2001/XMLSchema#string

Dietrich Tuerck

http://www.w3.org/2001/XMLSchema#string

Ivan Foeldvari

http://www.w3.org/2001/XMLSchema#string

Ronald Linke

http://www.w3.org/2001/XMLSchema#string

Rubén Burgos-Vargas

http://www.w3.org/2001/XMLSchema#string

P2860

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans

Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.

Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug.

Medical management of children with juvenile rheumatoid arthritis.

Stereoselective disposition of ibuprofen enantiomers in infants

Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance.

Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthriti

A review of the clinical pharmacokinetics of meloxicam.

Nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children.

P304

866-872

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0091270004267589

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rubén Burgos-Vargas

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8424149

http://www.w3.org/2001/XMLSchema#string

P698

15286090

http://www.w3.org/2001/XMLSchema#string